MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0016373
Mylin Biotech India Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.1 Cr
▲ 64% YoY
Net profit · FY 2025
₹1.06 Cr
Net margin 13.1%
EBITDA · FY 2025
₹1.81 Cr
EBITDA margin 22.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹3.45 Lakh
Issued & subscribed
Open charges
₹3.58 Cr
Satisfied ₹35 Lakh
Company age
14 yrs
Est. 2012
Employees · EPFO
15
Provident fund records
About Mylin Biotech India Private Limited
Data last updated:
Mylin Biotech India Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 10 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2012PTC067115. Its GSTIN is 29AAICM3171B1ZM (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.45 Lakh. It is led by directors including Kavitha Prabakaran and Ramasamy Ramajayam Pillai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #254/1 – 9 11th Main Road 3rd Phase Peenya, Bangalore Karnataka – 560058, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.1 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Cr (net margin 13.1%) and EBITDA of ₹1.81 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 34% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mylin Biotech. As per MCA filings, the company has open charges of ₹3.58 Cr and satisfied charges of ₹35 Lakh on record. The company has 1 deal on record (1 rights issue); the latest was in May 2022. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier.
Mylin Biotech India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0016373). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mylinbiotech.com.
Company details
CIN U73100KA2012PTC067115
Registration Number 067115
Incorporation Date 10 December 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0016373
Key People
Kavitha Prabakaran Director Ramasamy Ramajayam Pillai Director Pandurangan Prabhakran Director Recognitions & Rankings of Mylin Biotech India
Contact details
Mylin Biotech India Private Limited's registered office is in Bangalore, Karnataka. Its website is mylinbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#254/1 – 9 11th Main Road 3rd Phase Peenya, Bangalore Karnataka – 560058, Karnataka, India – 560058
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Mylin Biotech India Private Limited, buy the company report.
Comprehensive company report
Mylin Biotech India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mylin Biotech India operates one associated brand: Mylin Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotech company focusing on gut-centric healthcare solutions and manufacturing. | mylinbiotech.com |
Business activity
The main business activity of Mylin Biotech India is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mylin Biotech India Private Limited, buy the company report.
Financials of Mylin Biotech India Private Limited
FY 2025 filings availableMylin Biotech India Private Limited reported revenue of ₹8.1 Cr (up 64% YoY) for FY 2025.
Revenue · FY 2025
₹8.1 Cr ▲ 64%
Net profit · FY 2025
₹1.06 Cr margin 13.1%
EBITDA · FY 2025
₹1.81 Cr margin 22.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 62%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 644%
3 years · compounded
▲ 87%
5 years · compounded
▲ 56%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 64% growth in the latest year. EBITDA rose 644% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | ||||
| Net Profit Margin | 13.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mylin Biotech India Private Limited, buy the company report.
Board of directors of Mylin Biotech India Private Limited
Mylin Biotech India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavitha Prabakaran | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Ramasamy Ramajayam Pillai | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Pandurangan Prabhakran | Director | 09 May 2022 | 4 Years 5 Months | Current |
Auditor
Mylin Biotech India Private Limited is audited by AGARWAL JAIN S AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL JAIN S AND CO | FY 2023 | 021929S |
Shareholding
The shareholding of Mylin Biotech India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mylin Biotech India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.58 Cr
Satisfied charges
₹35 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Apr 2022 | 100569454 | State Bank of India | ₹3.26 Cr | Open | |
| 09 Dec 2020 | 100410128 | Hdfc Bank Limited | ₹32 Lakh | Open | |
| 20 May 2021 | 100447909 | Hdfc Bank Limited | ₹35 Lakh | Satisfied |
To see the full charge records of Mylin Biotech India Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Mylin Biotech India Private Limited has 1 deal on record (1 rights issue); the latest was in May 2022.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Rights issue | ₹33 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Mylin Biotech India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Mylin Biotech India Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mystical Biotech Private Limited |
To see the full MSME payment records of Mylin Biotech India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mylin Biotech India Private Limited has a workforce of 15 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
36.36%
GST
Mylin Biotech India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICM3171B1ZM | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mylin Biotech India Private Limited, buy the company report.
Recent activity
Mylin Biotech India Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Pandurangan Prabhakran ceased to be Additional Director on 30 Sep 2022.
AGM
Mylin Biotech India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mylin Biotech India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with State Bank Of India of Rs. 326.00 Lakh registered on 19 Apr 2022 with Charge ID 100569454 was modified on 09 Nov 2023.
Ceased
Pandurangan Prabhakran ceased to be Additional Director.
Charges
A charge registered on 20 May 2021 via Charge ID 100447909 with Hdfc Bank Limited was fully satisfied on 11 May 2022.
Appointed
Pandurangan Prabhakran was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 326.00 Lakh with Charge ID 100569454 was registered on 19 Apr 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 100447909 was registered on 20 May 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 32.00 Lakh with Charge ID 100410128 was registered on 09 Dec 2020.
Appointed
Kavitha Prabakaran was appointed as Director.
Appointed
Ramasamy Ramajayam Pillai was appointed as Director.
Incorporation
10 Dec 2012
Mylin Biotech India Private Limited was registered on 10 Dec 2012 with Roc Bangalore & aged 13 years 10 months as per MCA records.
Frequently asked questions
Mylin Biotech India is an active private limited company based in Bangalore, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 10 December 2012 (14+ years old) and is registered under CIN U73100KA2012PTC067115.
Mylin Biotech India has 3 current directors:
- Kavitha Prabakaran - Director
- Ramasamy Ramajayam Pillai - Director
- Pandurangan Prabhakran - Director
The latest financial statements of Mylin Biotech India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mylin Biotech India is 29AAICM3171B1ZM, registered in Karnataka.
The CIN (Corporate Identification Number) of Mylin Biotech India is U73100KA2012PTC067115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mylin Biotech India was incorporated on 10 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Mylin Biotech India has 1 deal on record (1 rights issue); the latest was in May 2022.
Pandurangan Prabhakran ceased to be Additional Director on 30 Sep 2022. Pandurangan Prabhakran was appointed as Director on 09 May 2022. Kavitha Prabakaran was appointed as Director on 10 Dec 2012. Mylin Biotech India has 4 board changes on record in total.
Yes, Mylin Biotech India is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0016373).
Mylin Biotech India has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Oct 2019.
Mylin Biotech India can be reached through the website mylinbiotech.com. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages